Title |
Combined inhaled anticholinergics and short‐acting beta<sub>2</sub>‐agonists for initial treatment of acute asthma in children
|
---|---|
Published in |
Cochrane database of systematic reviews, August 2013
|
DOI | 10.1002/14651858.cd000060.pub2 |
Pubmed ID | |
Authors |
Benedict Griffiths, Francine M Ducharme |
Abstract |
There are several treatment options for managing acute asthma exacerbations (sustained worsening of symptoms that do not subside with regular treatment and require a change in management). Guidelines advocate the use of inhaled short acting beta2-agonists (SABAs) in children experiencing an asthma exacerbation. Anticholinergic agents, such as ipratropium bromide and atropine sulfate, have a slower onset of action and weaker bronchodilating effect, but may specifically relieve cholinergic bronchomotor tone and decrease mucosal edema and secretions. Therefore, the combination of inhaled anticholinergics with SABAs may yield enhanced and prolonged bronchodilation. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | 12% |
Canada | 3 | 12% |
Paraguay | 1 | 4% |
Spain | 1 | 4% |
United States | 1 | 4% |
Japan | 1 | 4% |
Mexico | 1 | 4% |
Australia | 1 | 4% |
Chile | 1 | 4% |
Other | 1 | 4% |
Unknown | 11 | 44% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 21 | 84% |
Scientists | 2 | 8% |
Science communicators (journalists, bloggers, editors) | 1 | 4% |
Practitioners (doctors, other healthcare professionals) | 1 | 4% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 1% |
Colombia | 1 | <1% |
Canada | 1 | <1% |
Unknown | 288 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 38 | 13% |
Researcher | 33 | 11% |
Student > Bachelor | 33 | 11% |
Other | 22 | 8% |
Student > Postgraduate | 15 | 5% |
Other | 58 | 20% |
Unknown | 94 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 106 | 36% |
Nursing and Health Professions | 26 | 9% |
Unspecified | 12 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 3% |
Social Sciences | 7 | 2% |
Other | 24 | 8% |
Unknown | 109 | 37% |